ABO blood group and bleeding after coronary artery bypass graft surgery

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 8, 2007, Pages 781-785

  Welsby, Ian J ^a   Jones, Robert ^a   Pylman, John ^a   Mark, Jonathan B ^b   Brudney, Charles S ^b   Phillips Bute, Barbara ^a   Mathew, Joseph P ^a   Campbell, Mary Lee ^a   Stafford Smith, Mark ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Blood group; Coronary artery bypass; Hemostasis; Postoperative complications

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ANALYZER; ARTICLE; BLEEDING TIME; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEMODILUTION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; IN VITRO STUDY; INTRAOPERATIVE PERIOD; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURGICAL RISK; UNIVERSITY HOSPITAL;

ABO BLOOD-GROUP SYSTEM; AGED; BLOOD PLATELETS; COHORT STUDIES; CORONARY ARTERY BYPASS; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS; POSTOPERATIVE HEMORRHAGE;

EID: 35848957240     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f1029c     Document Type: Article

References (22)

1. Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998; 88:327-333.
2. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76:1680-1697.
3. Wahba A, Rothe G, Lodes H, Barlage S, Schmitz G, Birnbaum DE. Predictors of blood loss after coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1997; 11:824-827.
4. Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996; 82:13-21.
5. Hardy JF, Perrault J, Tremblay N, Robitaille D, Blain R, Carrier M. The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth 1991; 38:511-517.
6. Gelb AB, Roth RI, Levin J, London MJ, Noall RA, Hauck WW,et al. Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. Am J Clin Pathol 1996; 106:87-99.
7. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ, Factor VIII. ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994; 88:601-607.
8. Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986; 314:1402-1406.
9. Perrin EJ, Ray MJ, Hawson GA. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery. Blood Coagul Fibrinolysis 1995; 6:650-658.
10. Cattaneo M, Federici AB, Lecchi A, Agati B, Lombardi R, Stabile F, et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82:35-39.
11. Wahba A, Sander S, Birnbaum DE. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery? Thorac Cardiovasc Surg 1998; 46:228-231.
12. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001; 41:56-60.
13. Miller CH, Haff E, Platt SJ, Rawlins P, Drews CD, Dilley AB, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 2003; 1:2191-2197.
14. Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, et al. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 2003; 89:468-474.
15. O'Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001; 11:343-351.
16. Perutelli P. Proteolysis of von Willebrand factor is increased during cardiopulmonary bypass. Thromb Res 2001; 102:467-473.
17. Sweeney JD, Labuzetta JW, Hoernig LA, Fitzpatrick JE. Platelet function and ABO blood group. Am J Clin Pathol 1989; 91:79-81.
18. Holdright DR, Hunt BJ, Parratt R, Segal H, Clarke D, Taggart D, et al. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor. Eur J Cardiothorac Surg 1995; 9:18-21.
19. Caekebeke-Peerlinck KM, Koster T, Briet E. Bleeding time, blood groups and von Willebrand factor. Br J Haematol 1989; 73:217-220.
20. Slaughter TF, Sreeram G, Sharma AD, El-Moalem H, East CJ, Greenberg CS. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 2001; 12:85-93.
21. Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, et al. ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 1995; 68:236-240.
22. 1 allele and risk of myocardial infarction. Blood Coagul Fibrinolysis 2004; 15:61-67.